Searching around i found this one aswell.
FDA approval mid 2019. Injectable pain relieve.
May not have the benefits of iPPS but still competition.
https://www.google.com/url?sa=t&source=web&rct=j&url=https://www.durolane.com/en/what-is-durolane/&ved=2ahUKEwjYk83WwNXuAhWxzjgGHTwiDX4QFjAAegQIAxAC&usg=AOvVaw1GTTBmeC9HuARq3CPpYhuL
research reports and media, page-1182
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
26.0¢ |
Change
0.015(6.12%) |
Mkt cap ! $87.44M | |||
| Open | High | Low | Value | Volume |
| 24.5¢ | 26.0¢ | 24.5¢ | $23.76K | 93.21K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 20609 | 25.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 16164 | 2 |
View Market Depth
| Last trade - 12.49pm 01/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |